Detection of tissue factor-positive extracellular vesicles using the ExoView R100 system.

antigens, CD142 extracellular vesicles ovarian cancer tissue factor trauma

Journal

Research and practice in thrombosis and haemostasis
ISSN: 2475-0379
Titre abrégé: Res Pract Thromb Haemost
Pays: United States
ID NLM: 101703775

Informations de publication

Date de publication:
May 2023
Historique:
received: 21 11 2022
revised: 19 04 2023
accepted: 30 04 2023
medline: 19 6 2023
pubmed: 19 6 2023
entrez: 19 6 2023
Statut: epublish

Résumé

Tissue factor (TF) is essential for hemostasis. TF-expressing extracellular vesicles (TF We hypthesised that ExoView can allow for direct measurement of TF We utilized the anti-TF monoclonal antibody 5G9 to capture TF EV onto specialized ExoView chips. This was combined with fluorescent TF BxPC-3-derived TF TF

Sections du résumé

Background UNASSIGNED
Tissue factor (TF) is essential for hemostasis. TF-expressing extracellular vesicles (TF
Objectives UNASSIGNED
We hypthesised that ExoView can allow for direct measurement of TF
Methods UNASSIGNED
We utilized the anti-TF monoclonal antibody 5G9 to capture TF EV onto specialized ExoView chips. This was combined with fluorescent TF
Results UNASSIGNED
BxPC-3-derived TF
Conclusion UNASSIGNED
TF

Identifiants

pubmed: 37333992
doi: 10.1016/j.rpth.2023.100177
pii: S2475-0379(23)00150-4
pmc: PMC10276261
doi:

Types de publication

Journal Article

Langues

eng

Pagination

100177

Informations de copyright

© 2023 The Author(s).

Références

Res Pract Thromb Haemost. 2022 Mar 04;6(2):e12677
pubmed: 35284777
Thorax. 2021 Apr;76(4):412-420
pubmed: 33408195
Scand J Haematol. 1982 Aug;29(2):175-84
pubmed: 6813961
Blood Adv. 2021 Feb 9;5(3):628-634
pubmed: 33560376
J Thromb Haemost. 2019 Aug;17(8):1261-1264
pubmed: 31231949
Int J Mol Sci. 2020 Aug 29;21(17):
pubmed: 32872424
J Cell Mol Med. 2021 May;25(9):4455-4465
pubmed: 33797200
Thromb Res. 2012 Jan;129(1):80-5
pubmed: 21737126
Shock. 2017 Apr;47(4):409-415
pubmed: 27753793
Biochemistry. 2000 Jun 27;39(25):7380-7
pubmed: 10858285
J Thromb Haemost. 2006 Aug;4(8):1747-55
pubmed: 16879217
Thromb Res. 2016 May;141:39-48
pubmed: 26967531
Thromb Res. 2012 May;129 Suppl 2:S13-7
pubmed: 22398016
Nat Med. 2003 Apr;9(4):458-62
pubmed: 12652293
Sci Rep. 2021 Jan 8;11(1):94
pubmed: 33420117
J Extracell Vesicles. 2019 Apr 01;8(1):1596016
pubmed: 30988894
Res Pract Thromb Haemost. 2022 Jun 08;6(4):e12734
pubmed: 35702585
Blood. 1992 Dec 15;80(12):3127-34
pubmed: 1467519
Scientifica (Cairo). 2012;2012:964862
pubmed: 24278763
Thromb Res. 1988 Nov 1;52(3):247-61
pubmed: 3194899
Thromb Res. 2020 Dec;196:414-424
pubmed: 33038585
Thromb Res. 2011 May;127(5):473-7
pubmed: 21256535
Thromb Res. 2010 Jan;125(1):90-6
pubmed: 19345399
Nat Protoc. 2021 Jul;16(7):3163-3185
pubmed: 34135505
Blood. 1987 Aug;70(2):490-3
pubmed: 3607285
BMC Cancer. 2015 Apr 15;15:290
pubmed: 25886038
Malays J Pathol. 2002 Jun;24(1):45-51
pubmed: 16329555
Sci Rep. 2016 Nov 17;6:37246
pubmed: 27853258
Blood. 2007 Feb 1;109(3):995-1002
pubmed: 17003379
Thromb Res. 2010 Apr;125 Suppl 1:S31-4
pubmed: 20149415
Nat Rev Cardiol. 2021 Sep;18(9):666-682
pubmed: 33958774
Int J Mol Sci. 2020 May 21;21(10):
pubmed: 32455533
Transfusion. 2021 Jul;61(7):2179-2194
pubmed: 33948950
Arterioscler Thromb Vasc Biol. 2005 Jul;25(7):1493-8
pubmed: 15860742
J Hematol Oncol. 2012 Jul 11;5:16
pubmed: 22534171
J Extracell Vesicles. 2015 Mar 13;4:26901
pubmed: 25773446
Blood. 2015 Mar 26;125(13):2151-9
pubmed: 25628471
Clin Biochem. 1992 Apr;25(2):77-87
pubmed: 1623581
J Thromb Haemost. 2021 Nov;19(11):2652-2658
pubmed: 34418279
Immunol Rev. 2022 Nov;312(1):61-75
pubmed: 35708588
Res Pract Thromb Haemost. 2018 Nov 20;3(1):44-48
pubmed: 30656275
Perit Dial Int. 2015 Sep-Oct;35(5):599-602
pubmed: 26450485
BMC Cancer. 2011 Jun 22;11:263
pubmed: 21693061
PLoS Med. 2017 Jul 18;14(7):e1002338
pubmed: 28719602
Br J Cancer. 2022 Dec;127(12):2099-2107
pubmed: 36097177
Am J Physiol Lung Cell Mol Physiol. 2022 Apr 1;322(4):L617-L624
pubmed: 35234046
Thromb Haemost. 2000 Apr;83(4):589-91
pubmed: 10780322
Biol Chem. 1998 Feb;379(2):157-65
pubmed: 9524067
Trends Biotechnol. 2020 Oct;38(10):1066-1098
pubmed: 32564882
Br J Cancer. 2007 Jan 29;96(2):290-5
pubmed: 17211468
Thromb Haemost. 1991 Nov 1;66(5):529-33
pubmed: 1803616
Br J Haematol. 1994 Jun;87(2):343-7
pubmed: 7947277
Cell. 1987 Jul 3;50(1):129-35
pubmed: 3297348
Blood Coagul Fibrinolysis. 1992 Jun;3(3):263-70
pubmed: 1643203
Int J Mol Sci. 2022 Aug 01;23(15):
pubmed: 35955677
Sci Rep. 2020 Dec 7;10(1):21346
pubmed: 33288809
J Mol Biol. 1998 Feb 6;275(5):873-94
pubmed: 9480775
Cancer Sci. 2021 Nov;112(11):4679-4691
pubmed: 34382298
J Biochem. 1993 Nov;114(5):691-6
pubmed: 8113222
Arterioscler Thromb Vasc Biol. 2018 Apr;38(4):709-725
pubmed: 29437578
Cancers (Basel). 2021 Jul 30;13(15):
pubmed: 34359742
Res Pract Thromb Haemost. 2017 Oct 16;2(1):42-48
pubmed: 30046705

Auteurs

Joshua M J Price (JMJ)

Institute of Inflammation and Ageing, University of Birmingham, Birmingham, United Kingdom.

Yohei Hisada (Y)

Division of Hematology and Oncology, UNC Blood Research Center, Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.

Jon Hazeldine (J)

Institute of Inflammation and Ageing, University of Birmingham, Birmingham, United Kingdom.

Victoria Bae-Jump (V)

Division of Gynecologic Oncology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
Department of Medicine, Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.

Thomas Luther (T)

Institute of Pathology, Technical University Dresden, Dresden, Germany.

Nigel Mackman (N)

Division of Hematology and Oncology, UNC Blood Research Center, Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.

Paul Harrison (P)

Institute of Inflammation and Ageing, University of Birmingham, Birmingham, United Kingdom.

Classifications MeSH